ALTAVERE LABS
LIVE

Serial Number

99704725

Owner

Shankargouda Patil

Attorney

Scott H. Blackman

Filing Date

Mar 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ALTAVERE LABS Trademark

Serial Number: 99704725

ALTAVERE LABS is a trademark filed by Shankargouda Patil on March 16, 2026. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Shankargouda Patil

1433 W Pinyon Pines Way
South Jordan, UT 84095

Entity Type: 01

ALTAVERE LABS, LLC

108 LAKELAND AVE.
DOVER, DE 19901

Entity Type: 16

Trademark Details

Filing Date

March 16, 2026

Registration Date

Not Registered

Goods & Services

Surgical devices and instruments; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Wearable monitors used to measure biometric data for medical use; Body rehabilitation apparatus for medical purposes; Medical imaging apparatus; Dental implants; Orthodontic appliances; Prosthetic instruments for dental purposes; Endodontic apparatus; Medical apparatus and instruments for use in oral and maxillofacial surgical procedures; dental diagnostic and imaging procedures; endodontic procedures; periodontal procedures; orthodontic procedures; prosthodontic procedures; oral cancer screening and detection; biopsy and histopathological specimen collection; point-of-care diagnostic testing; intraoral and extraoral imaging; cephalometric and radiographic analysis; salivary diagnostics; and biosensor-based health monitoring procedures

Software as a service (SAAS) services featuring software for use in healthcare and life sciences data analysis; Software as a service (SAAS) services featuring software for clinical decision support; Software as a service (SAAS) services featuring software for analysis of medical images and medical imaging data; Software as a service (SAAS) services featuring software for bioinformatics and computational biology; Software as a service (SAAS) services featuring software for drug discovery and molecular design; Software as a service (SAAS) services featuring software for clinical trial design and optimization; Software as a service (SAAS) services featuring software for electronic health record data analytics; Software as a service (SAAS) services featuring software for remote patient monitoring data analytics; Software as a service (SAAS) services featuring software for medical diagnostic and prognostic analytics; Software as a service (SAAS) services featuring software for genomics and multi-omics data analysis; Providing temporary use of on-line non-downloadable software for managing and analyzing biomedical and clinical research data; Providing temporary use of on-line non-downloadable software for laboratory information management; Application service provider featuring application programming interface (API) software; Design and development of computer software; Computer software consultancy; Cloud computing featuring software for use in healthcare and life sciences

Toothpaste; Tooth powder; Non-medicated mouthwashes; Non-medicated mouth rinse; Breath freshening preparations for personal hygiene; Tooth whitening preparations; Dental bleaching gel; Preparations for cleaning dentures; Cosmetic preparations for the care of mouth and teeth; Non-medicated body care preparations, namely, creams, lotions, gels, and serums; Non-medicated hair care preparations, namely, shampoos, conditioners, and hair lotions

Vaccines; Dietary supplements; Nutritional supplements; Vitamin and mineral supplements; Amino acids for nutritional purposes; Probiotic supplements; Prebiotic supplements; Dietetic foods adapted for medical use; Medicated mouthwash; Medicated dental rinses; Medicated toothpaste; Mouthwashes for medical purposes; Dental varnish for use by dentists; Dental cements; Materials for dental fillings; Dental impression materials; Dental adhesives; Hemostatics for medical purposes; Hemostatics for dental purposes; Dental sealants; Wound dressings; Essential oils for aromatherapy use; Pharmaceutical preparations for the treatment and prevention of oral and oropharyngeal cancers; oral potentially malignant disorders including leukoplakia, erythroplakia, and oral submucous fibrosis; periodontal diseases including gingivitis and periodontitis; dental caries; oral mucositis; oral candidiasis and other fungal infections of the oral cavity; medication-related osteonecrosis of the jaw (MRONJ); temporomandibular joint disorders; xerostomia; diabetes and metabolic disorders; cardiovascular diseases; neurodegenerative diseases; Pharmaceutical preparations for the treatment and prevention of autoimmune and inflammatory conditions; bone and joint disorders including osteoporosis and osteoarthritis; infectious diseases; gastrointestinal disorders; respiratory diseases; dermatological conditions; nutritional deficiencies; pain and inflammation; sleep disorders; anxiety and stress-related conditions; and immune system disorders; Pharmaceutical preparations for prevention and treatment of dental caries; enamel remineralization and strengthening; prevention and treatment of periodontal diseases including gingivitis and periodontitis; prevention and treatment of oral mucositis; management of xerostomia and dry mouth; treatment of dentinal hypersensitivity; prevention and treatment of oral infections including candidiasis; promotion of oral wound healing; management of halitosis; maintenance of oral microbiome balance; Pharmaceutical preparations for prevention and treatment of peri-implant diseases including peri-implantitis; support for post-surgical oral tissue recovery; gingival tissue regeneration; management of oral lichen planus; management of recurrent aphthous ulcers; tooth whitening and stain prevention; and general oral and dental hygiene maintenance

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 3, 2026 ASGN
APPLICATION FILING RECEIPT MAILED
Mar 16, 2026 MAFR
NEW APPLICATION ENTERED
Mar 16, 2026 NWAP